Data / Form D filings / Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc.: Form D filings
Kriya Therapeutics, Inc., a biotechnology company in Morrisville, NC, filed 7 Form D notices with the SEC between 2020 and 2025. The latest, on September 10, 2025, reports $320.8 million sold of a $320.8 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4105 HOPSON ROAD, Morrisville, NC, 27560
- Phone
- (833) 574-9289
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1811209
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | Amendment | $320,822,412 | $320,822,412 | 10 | Jul 31, 2025 | sec.gov | |
| Aug 15, 2025 | New notice | $313,297,440 | $313,297,440 | 2 | Jul 31, 2025 | sec.gov | |
| Jul 27, 2023 | Amendment | $432,044,499 | $361,794,505 | $70,249,994 | 29 | May 10, 2022 | sec.gov |
| May 24, 2022 | New notice | $300,544,558 | $270,544,561 | $29,999,997 | 20 | May 10, 2022 | sec.gov |
| Jul 14, 2021 | New notice | $99,999,999 | $99,999,999 | 36 | Jun 30, 2021 | sec.gov | |
| Aug 18, 2020 | Amendment | $87,634,918 | $87,634,885 | $33 | 21 | May 4, 2020 | sec.gov |
| May 19, 2020 | New notice | $85,634,918 | $85,634,886 | $32 | 20 | May 4, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Neelaksh Varshney | Director | |
| Michele Stone | Executive Officer | |
| Ilan Oren | Director | |
| Saira Ramasastry | Director | |
| Ryan Gallagher | Director | |
| Keith Manchester | Director | |
| Katherine Eade | Executive Officer | |
| James Momtazee | Director | |
| Akshay Rai | Director | |
| Shankar Ramaswamy | Executive Officer, Director | |
| Curt Herberts | Executive Officer | |
| Britt Petty | Executive Officer | |
| Roger Jeffs | Director | |
| Brian Furmanski | Executive Officer | |
| Trit Garg | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Sep 8, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kriya Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.